glp 1 moa GLP-1 Agonists - What is it? Mechanism of action of GLP-1
Description
10 aprile 2013;114115:3841

However, this offer only applies to vials of the drug, not the autoinjector pens

This medications safety profile has not been studied in patients under the age of 18, pregnant and lactating people, or those with normal BMIs. At the time of publishing, the FDA has only approved three GLP-1 agonists for weight loss: Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)

If you are ready to move from questions to action, you can complete the free assessment quiz

In addition, there is the potential for an increased incidence of hypersensitivity reactions such as injection-site reactions

doi: 10.1016/j.atherosclerosis.2013.08.033
